BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12859967)

  • 1. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.
    Hsieh HL; Schäfer BW; Sasaki N; Heizmann CW
    Biochem Biophys Res Commun; 2003 Jul; 307(2):375-81. PubMed ID: 12859967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A6 protein: functional roles.
    Donato R; Sorci G; Giambanco I
    Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joining S100 proteins and migration: for better or for worse, in sickness and in health.
    Gross SR; Sin CG; Barraclough R; Rudland PS
    Cell Mol Life Sci; 2014 May; 71(9):1551-79. PubMed ID: 23811936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
    Nasser MW; Wani NA; Ahirwar DK; Powell CA; Ravi J; Elbaz M; Zhao H; Padilla L; Zhang X; Shilo K; Ostrowski M; Shapiro C; Carson WE; Ganju RK
    Cancer Res; 2015 Mar; 75(6):974-85. PubMed ID: 25572331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conserving surgery versus mastectomy: a prospective observational study.
    Jacobs LM; Helder LS; Albers KI; Kranendonk J; Keijzer C; Joosten LA; Strobbe LJ; Warlé MC
    Breast Cancer Res; 2024 Mar; 26(1):42. PubMed ID: 38468349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
    Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer.
    Magna M; Hwang GH; McIntosh A; Drews-Elger K; Takabatake M; Ikeda A; Mera BJ; Kwak T; Miller P; Lippman ME; Hudson BI
    NPJ Breast Cancer; 2023 Jul; 9(1):59. PubMed ID: 37443146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
    Talia M; Cirillo F; Spinelli A; Zicarelli A; Scordamaglia D; Muglia L; De Rosis S; Rigiracciolo DC; Filippelli G; Perrotta ID; Davoli M; De Rosa R; Macirella R; Brunelli E; Miglietta AM; Nardo B; Tosoni D; Pece S; De Francesco EM; Belfiore A; Maggiolini M; Lappano R
    J Exp Clin Cancer Res; 2023 Jul; 42(1):164. PubMed ID: 37434266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.
    Faruqui T; Khan MS; Akhter Y; Khan S; Rafi Z; Saeed M; Han I; Choi EH; Yadav DK
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AllergoOncology: Role of immune cells and immune proteins.
    Di Gioacchino M; Della Valle L; Allegra A; Pioggia G; Gangemi S
    Clin Transl Allergy; 2022 Mar; 12(3):e12133. PubMed ID: 35344301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.
    Lin M; Fang Y; Li Z; Li Y; Feng X; Zhan Y; Xie Y; Liu Y; Liu Z; Li G; Shen Z; Deng H
    Br J Cancer; 2021 Aug; 125(5):734-747. PubMed ID: 34188196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer.
    Chen MC; Chen KC; Chang GC; Lin H; Wu CC; Kao WH; Teng CJ; Hsu SL; Yang TY
    Cell Death Dis; 2020 Apr; 11(4):265. PubMed ID: 32327633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma.
    Li R; Song Y; Zhou L; Li W; Zhu X
    Onco Targets Ther; 2020; 13():2385-2397. PubMed ID: 32256089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
    Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
    Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Oczypok EA; Perkins TN; Oury TD
    Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
    Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
    Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.
    Lim MY; Thomas PS
    Int J Chronic Dis; 2013; 2013():578613. PubMed ID: 26464846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer.
    Wang H; Li Y; Yu W; Ma L; Ji X; Xiao W
    Oncol Lett; 2015 Jul; 10(1):51-60. PubMed ID: 26170976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.